Jiangbo Pharmaceuticals Inc. (JGBO.OB) Posts Strong Q4 and FY09 Results, High Expectancies for 2010
Jiangbo Pharmaceuticals Inc. today announced its fiscal and fourth-quarter results for the period ended June 30, 2009. The China-based pharmaceutical company posted solid results for both periods and gave a summary of achievements for the year, as well as its outlook for 2010. "We are delighted to report a strong finish to fiscal 2009, with revenues and operating income significantly exceeding our prior guidance for the year. We believe that the factors that contributed to this performance were strong sales from our new products and the successful restructuring of our sales and marketing network. With nearly $63 million in operating…